MetaADEDB 2.0 @ LMMD
Prochlorperazine
(SWOUGRBFXFILIB-UHFFFAOYSA-N)
Structure
SMILES
OS(=O)(=O)CCS(=O)(=O)O.CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2
Molecular Formula:
C22H30ClN3O6S3
Molecular Weight:
564.138
Log P:
5.4446
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
2
TPSA:
160.52
CAS Number(s):
1257-78-9
Synonym(s)
1.
Prochlorperazine
2.
Compazine
3.
Prochlorperazine Edisylate
4.
Prochlorperazine Edisylate Salt
5.
Prochlorperazine Maleate
6.
Edisylate Salt, Prochlorperazine
7.
Edisylate, Prochlorperazine
8.
Maleate, Prochlorperazine
9.
Salt, Prochlorperazine Edisylate
External Link(s)
MeSHD011346
PubChem Compound91499
CHEMBLCHEMBL1201154
KEGGdr:D02609
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Dissociative disorderFAERS: 1US FAERS
2DystoniaFAERS: 1US FAERS
3HypotensionFAERS: 1US FAERS
4Sinus TachycardiaFAERS: 1US FAERS
5Tardive DyskinesiaFAERS: 1US FAERS
6AbasiaOFFSIDES
7Abdominal PainOFFSIDES
8AcidosisOFFSIDES
9AlopeciaOFFSIDES
10AlveolitisOFFSIDES
11AngerOFFSIDES
12AnorexiaOFFSIDES
13Aspiration PneumoniaOFFSIDES
14AstheniaOFFSIDES
15AtelectasisOFFSIDES
16Bifascicular blockOFFSIDES
17BlastomycosisOFFSIDES
18Blood GlucoseOFFSIDES
19Blood urine presentOFFSIDES
20Catheter related infectionOFFSIDES
21Cerebral PalsyOFFSIDES
22CholecystitisOFFSIDES
23Circumstance or information capable of leading to medication errorOFFSIDES
24CirrhosisOFFSIDES
25ColitisOFFSIDES
26Culture positiveOFFSIDES
27DehydrationOFFSIDES
28DiabetesOFFSIDES
29DiarrheaOFFSIDES
30Disease recurrenceOFFSIDES
31Drug abuserOFFSIDES
32Drug withdrawal headacheOFFSIDES
33DyspepsiaOFFSIDES
34Escherichia infectionOFFSIDES
35Euphoric moodOFFSIDES
36Facial NeuralgiaOFFSIDES
37Failure to ThriveOFFSIDES
38FatigueOFFSIDES
39Febrile NeutropeniaOFFSIDES
40Gas GangreneOFFSIDES
41HemiparesisOFFSIDES
42HypophagiaOFFSIDES
43HypoxiaOFFSIDES
44Intestinal PerforationOFFSIDES
45Intestinal infarctionOFFSIDES
46Kidney FailureOFFSIDES
47LaryngospasmOFFSIDES
48Left Ventricular HypertrophyOFFSIDES
49LethargyOFFSIDES
50Limb crushing injuryOFFSIDES
51LipaseOFFSIDES
52Mental retardation severity unspecifiedOFFSIDES
53Metabolic acidosisOFFSIDES
54NauseaOFFSIDES
55NeuralgiaOFFSIDES
56OliguriaOFFSIDES
57Optic Disc EdemaOFFSIDES
58Optic NeuritisOFFSIDES
59OverdoseOFFSIDES
60PancreatitisOFFSIDES
61Pericardial effusionOFFSIDES
62PneumothoraxOFFSIDES
63Portal Vein ThrombosisOFFSIDES
64Postoperative infectionOFFSIDES
65Procedural complicationOFFSIDES
66Protein total decreasedOFFSIDES
67Prothrombin time abnormalOFFSIDES
68Respiratory FailureOFFSIDES
69SalmonellaOFFSIDES
70ThrombophlebitisOFFSIDES
71ToxoplasmosisOFFSIDES
72Unevaluable eventOFFSIDES
73Vitamin B 12 DeficiencyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.